GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » PB Ratio

AstraZeneca Pharma India (BOM:506820) PB Ratio : 24.30 (As of Dec. 15, 2024)


View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), AstraZeneca Pharma India's share price is ₹6603.60. AstraZeneca Pharma India's Book Value per Share for the quarter that ended in Sep. 2024 was ₹271.74. Hence, AstraZeneca Pharma India's PB Ratio of today is 24.30.

The historical rank and industry rank for AstraZeneca Pharma India's PB Ratio or its related term are showing as below:

BOM:506820' s PB Ratio Range Over the Past 10 Years
Min: 9.76   Med: 15.96   Max: 28.66
Current: 24.3

During the past 13 years, AstraZeneca Pharma India's highest PB Ratio was 28.66. The lowest was 9.76. And the median was 15.96.

BOM:506820's PB Ratio is ranked worse than
97.98% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs BOM:506820: 24.30

During the past 12 months, AstraZeneca Pharma India's average Book Value Per Share Growth Rate was 3.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 16.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 18.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 16.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of AstraZeneca Pharma India was 26.80% per year. The lowest was -11.60% per year. And the median was 14.95% per year.

Back to Basics: PB Ratio


AstraZeneca Pharma India PB Ratio Historical Data

The historical data trend for AstraZeneca Pharma India's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India PB Ratio Chart

AstraZeneca Pharma India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.41 16.50 12.49 13.79 18.68

AstraZeneca Pharma India Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.19 - 18.68 - 29.32

Competitive Comparison of AstraZeneca Pharma India's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Pharma India's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's PB Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca Pharma India's PB Ratio falls into.



AstraZeneca Pharma India PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AstraZeneca Pharma India's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=6603.60/271.74
=24.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


AstraZeneca Pharma India  (BOM:506820) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


AstraZeneca Pharma India PB Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Pharma India Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines.

AstraZeneca Pharma India Headlines

No Headlines